O24. Is there any cardiovascular effect of carbetocin utilization that might prevent its use in preeclampsia? A TVR and CO study.

Pisani, I; Tiralongo, G M; Gagliardi, G; Scala, R L; Todde, C; Frigo, M G; Valensise, H

Pisani, I; Tiralongo, G M; Gagliardi, G; Scala, R L; Todde, C; Frigo, M G; Valensise, H.

Afiliación

Pisani I; Department of Obstetric and Gyneacology, University of Tor Vergata, Rome, Italy.
Tiralongo GM; Department of Obstetric and Gyneacology, University of Tor Vergata, Rome, Italy.
Gagliardi G; Department of Obstetric and Gyneacology, University of Tor Vergata, Rome, Italy.
Scala RL; Department of Obstetric and Gyneacology, University of Tor Vergata, Rome, Italy.
Todde C; UOS Anesthesia and rianimation in Obstetric and Gynecology, Fatebenefratelli San Giovanni Calibita Hospital, Rome, Italy.
Frigo MG; UOS Anesthesia and rianimation in Obstetric and Gynecology, Fatebenefratelli San Giovanni Calibita Hospital, Rome, Italy.
Valensise H; Department of Obstetric and Gyneacology, University of Tor Vergata, Rome, Italy.

Pregnancy Hypertens ; 1(3-4): 269-70, 2011.

Article en En | MEDLINE | ID: mdl-26009086

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pregnancy Hypertens Año: 2011 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google